• 1
    Sagmeister M, Mullhaupt B, Kadry Z, Kullak-Ublick GA, Clavien PA, Renner EL. Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation 2002; 73: 616622.
  • 2
    Younossi ZM, McCormick M, Price LL et al. Impact of liver transplantation on health-related quality of life. Liver Transpl 2000; 6: 779783.
  • 3
    Starzl TE. Evolution of liver transplantation. Hepatology 1982; 2: 614636.
  • 4
    Consensus Conference on Indications of Liver Transplantation. Hepatology 1994; 20: S1S68.
  • 5
  • 6
    Kusne S, Dummer JS, Singh N et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine ( Baltimore ) 1988; 67: 132143.
  • 7
    George DL, Arnow PM, Fox AS et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991; 13: 387396.
  • 8
    Gould L, Patel A. Ultrasound detection of extrahepatic encapsulated bile: ‘biloma’. AJR Am J Roentgenol 1979; 132: 10141015.
  • 9
    Hollenbeak CS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery 2001; 130: 388395.
  • 10
    Tachopoulou OA, Vogt DP, Henderson JM, Baker M, Keys TF. Hepatic abscess after liver transplantation: 1990–2000. Transplantation 2003; 75: 7983.
  • 11
    Kaplan SB, Zajko AB, Koneru B. Hepatic bilomas due to hepatic artery thrombosis in liver transplant recipients: percutaneous drainage and clinical outcome. Radiology 1990; 174: 10311035.
  • 12
    Margarit C, Hidalgo E, Lazaro JL, Murio E, Charco R, Balsells J. Biliary complications secondary to late hepatic artery thrombosis in adult liver transplant patients. Transpl Int 1998; 11: S251S254.
  • 13
    Limaye AP, Gautom RK, Black D, Fritsche TR. Rapid emergence of resistance to cefepime during treatment. Clin Infect Dis 1997; 25: 339340.
  • 14
    Friedl J, Stift A, Berlakovich GA et al. Haemophilus parainfluenzae liver abscess after successful liver transplantation. J Clin Microbiol 1998; 36: 818819.
  • 15
    Rabkin JM, Orloff SL, Reed MH et al. Biliary tract complications of side-to-side without T tube versus end-to-end with or without T tube choledochocholedochostomy in liver transplant recipients. Transplantation 1998; 65: 193199.
  • 16
    D'Alessandro AM, Hoffmann RM, Knechtle SJ et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000; 128: 579588.
  • 17
    Lemeshow S, Hosmer DW Jr A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982; 115: 92106.
  • 18
    Stratta RJ, Wood RP. Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery 1989; 106: 675684.
  • 19
    Grief F, Bronshter OL. The incidence, timing and managment of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994; 219: 4045.
  • 20
    Sherman S, Jamidar P. Biliary tract complications after orthotopic liver transplantation. Transplantation 1995; 60: 467470.
  • 21
    Said A, Safdar N, Lucey MR et al. Infected bilomas post liver transplantation. II. Diagnosis, outcome and mortality. Abstract presented at American Transplant Conference, Washington D.C. , May 2003.
  • 22
    McDonald MI, Corey GR, Gallis HA, Durack DT. Single and multiple pyogenic liver abscesses. Natural history, diagnosis and treatment, with emphasis on percutaneous drainage. Medicine 1984; 63: 291302.
  • 23
    Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerging Infect Dis 2001; 7: 188192.
  • 24
    Maki DG, Nosocomial infection in the intensive care unit. In: ParilloJE, BoneR, eds. Critical Care Medicine. St. Louis : Mosby , 2002: 893954.
  • 25
    O'Connor TP, Lewis DW, Jenkins RL. Biliary tract complications after liver transplantation. Arch Surg 1995; 130: 312317.
  • 26
    Binmoeller KF, Katon RM, Shneidmna R. Endoscopic managment of postoperative biliary leaks. review of 77 cases and report of two cases with biloma formation. Am J Gastroenterology 1991; 86: 222231.
  • 27
    Rabkin JM, Orloff SL, Corless CL et al. Hepatic allograft abscess with hepatic arterial thrombosis. Am J Surg 1998; 175: 354359.
  • 28
    Bhattacharjya S, Gunson BK, Mirza DF et al. Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-a 12-year experience. Transplantation 2001; 71: 15921596.
  • 29
    Langnas AN, Marujo W, Stratta RJ, Wood RP, Shaw BW Jr Vascular complications after orthotopic liver transplantation. Am J Surg 1991; 161: 7682; discussion 82–73.
  • 30
    Stange BJ, Glanemann M, Nuessler NC, Settmacher U, Steinmuller T, Neuhaus P. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl 2003; 9: 612620.
  • 31
    Wozney P. Vascular complications after liver transplantation: a 5 years experience. AJR 1986; 147: 657663.
  • 32
    Tzakis AG. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985; 40: 667671.
  • 33
    Madalosso C, De Souza NF Jr, Ilstrup DM, Wiesner RH, Krom RA. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 1998; 66: 294297.
  • 34
    Gunsar F, Rolando N, Pastacaldi S et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl 2003; 9: 605611.
  • 35
    Oh CK, Pelletier SJ, Sawyer RG et al. Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation 2001; 71: 767772.
  • 36
    Vivarelli M, La Barba G, Legnani C et al. Repeated graft loss caused by recurrent hepatic artery thrombosis after liver transplantation. Liver Transpl 2003; 9: 629631.
  • 37
    Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990; 12: 553558.
  • 38
    Hashikura Y. Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation 1995; 60: 11091112.
  • 39
    Wolf DC. Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. Liver Transpl Surg 1997; 3: 598603.
    Direct Link:
  • 40
    Theilmann L, Kuppers B, Kadmon M et al. Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy 1994; 26: 517522.
  • 41
    Colonna JO 2nd, Shaked A, Gomes AS et al. Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg 1992; 216: 344350; discussion 350–342.
  • 42
    Porayko MK, Kondo M, Steers JL. Liver transplantation: late complications of the biliary tract and their management. Semin Liver Dis 1995; 15: 139155.
  • 43
    O'Connor TP, Lewis WD, Jenkins RL. Biliary tract complications after liver transplantation. Arch Surg 1995; 130: 312317.
  • 44
    Randall HB, Wachs ME, Somberg KA et al. The use of the T tube after orthotopic liver transplantation. Transplantation 1996; 61: 258261.
  • 45
    Rolles K, Dawson K, Novell R, Hayter B, Davidson B, Burroughs A. Biliary anastomosis after liver transplantation does not benefit from T tube splintage. Transplantation 1994; 57: 402404.
  • 46
    Ferraz-Neto BH, Mirza DF, Gunson BK et al. Bile duct splintage in liver transplantation: is it necessary Transpl Int 1996; 9: S185S187.
  • 47
    Koivusalo A, Isoniemi H, Salmela K, Hockerstedt K. Biliary complications in 100 adult liver transplantations: a retrospective clinical study. Transpl Int 1994; 7: S119S120.
  • 48
    Ben-Ari Z, Neville L, Davidson B, Rolles K, Burroughs AK. Infection rates with and without T-tube splintage of common bile duct anastomosis in liver transplantation. Transpl Int 1998; 11: 123126.
  • 49
    Jacobs LK, Shayani V, Sackier JM. Common bile duct T-tubes. A caveat and recommendations for management. Surg Endosc 1998; 12: 6062.
  • 50
    Rouch DA, Emond JC, Thistlethwaite JR Jr, Mayes JT, Broelsch CE. Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. Surg Gynecol Obstet 1990; 170: 239244.
  • 51
    Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology 1991; 14: 10631065.
  • 52
    Plaisier PW, Van Der Hul RL, Lameris JS, Oie HY, Terpstra OT. Routine testing of liver function after biliary-enteric anastomosis has no clinical relevance. Hepatogastroenterology 2001; 48: 622624.
  • 53
    Trauner M, Graziadei WI. Review article: mechanisms of action and therapeutic applications or ursodeoxycholic acid in chronic liver diseases. Aliment Pharmacol Ther 1999; 13: 979995.
  • 54
    Soderdahl G, Nowak G, Duraj F, Wang FH, Einarsson C, Ericzon BG. Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation. Transpl Int 1998; 11: S231S238.
  • 55
    Heuman DM. Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology 1993; 104: 18651869.
  • 56
    Calmus Y, Gane P. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid. Hepatology 1990; 11: 1215.
  • 57
    Heathcote EJ, Stone J, Cauch-Dudek K et al. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Liver Transpl Surg 1999; 5: 269274.
  • 58
    Fleckenstein JF, Paredes M, Thuluvath PJ. A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection. Liver Transpl Surg 1998; 4: 276279.
  • 59
    Barnes D, Talenti D, Cammell G et al. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection. Hepatology 1997; 26: 853857.